UTEC - The University of Tokyo Edge Capital Partners portfolio companies
Updated 16 Nov 2026
Not sure about the data?
Download a free 10-row sample first. No account, no payment.
| Company | City | Last round | Amount | Date |
|---|---|---|---|---|
| Mujin | Tokyo | Series D | $224.9M | 2026-10-12 |
| BionicM | Tokyo | Series B | $4.5M | 2026-11-02 |
| Celaid Therapeutics | Tokyo | Series B | $2.5M | 2026-10-05 |
| Triorb | Kitakyushu | Series B | $1.9M | 2026-08-07 |
| VividQ | Cambridge | Series A | $7.5M | 2024-08-21 |
| TXP Medical | Tokyo | Series C | $16.1M | 2024-10-23 |
| Eureka Robotics | Singapore | Series A | $10.5M | 2024-12-12 |
| Forest | Tokyo | Series B | $27.3M | 2025-10-06 |
8 rows of the CSV in 5 of its 18 columns.
- The 24 UTEC - The University of Tokyo Edge Capital Partners portfolio companies have raised $808.5M in total.
- 4 of them closed their most recent round in the last 12 months, $233.8M combined.
- The largest of those rounds is Mujin's $224.9M Series D, dated October 2026.
- The most recent is BionicM's $4.5M Series B on 2 November 2026.
- UTokyo Innovation Platform is an investor in 4 of them, more than any other fund.
- Software is the most common sector, with 19 companies (79%).
- 21% were founded in 2020 or later; the median founding year is 2018.
- The most common team size is 11 to 50 employees (62% of companies with a recorded size).
Source: FundingWatcher. Data as of 16 November 2026. "Last 12 months" is the 365 days to that date.
Newest rounds
9 of 24| Company | What they do | Sector | Location | Last round | Amount | Date | Total raised | Investors | Employees | Founded |
|---|---|---|---|---|---|---|---|---|---|---|
| BionicM | BionicM develops high-performance robotic prostheses that improve mobility for people with disabilities. | Hardware | Tokyo, Japan | Series B | $4.5M | 2026-11-02 | $15.5M | UTEC - The University of Tokyo Edge Capital Partners, UTokyo Innovation Platform, Shinsei Corporate Investment +1 | 11 to 50 | 2018 |
| Mujin | Mujin provides automation solutions for industrial robots in factories and logistics. | Artificial intelligence | Tokyo, Japan | Series D | $224.9M | 2026-10-12 | $634.7M | SBI Investment, Pegasus Tech Ventures, UTEC - The University of Tokyo Edge Capital Partners | 251 to 500 | 2011 |
| Celaid Therapeutics | Celaid Therapeutics develops cell therapies for blood cancer, intractable blood diseases, and genetic disorders. | Biotech | Tokyo, Japan | Series B | $2.5M | 2026-10-05 | $17.1M | UTEC - The University of Tokyo Edge Capital Partners, Osaka University Venture Capital, Joyo Capital Partners | 1 to 10 | 2020 |
| Triorb | Triorb develops software and hardware solutions for robot mobility. | Hardware | Kitakyushu, Japan | Series B | $1.9M | 2026-08-07 | $28.7M | Mitsubishi UFJ Capital, UTEC - The University of Tokyo Edge Capital Partners, MIRAI SOUZOU | 11 to 50 | 2023 |
| Forest | Forest is an e-commerce platform that acquires third-party brands and uses algorithm insights to market them. | Commerce | Tokyo, Japan | Series B | $27.3M | 2025-10-06 | $55.0M | UTEC - The University of Tokyo Edge Capital Partners, Nordstar, Resona Bank +1 | 11 to 50 | 2021 |
| TXP Medical | TXP Medical develops medical data systems for emergency and intensive care, cancer treatment, and medical AI. | Health care | Tokyo, Japan | Series C | $16.1M | 2024-10-23 | $18.4M | UTEC - The University of Tokyo Edge Capital Partners, MPower Partners | 11 to 50 | 2017 |
| VividQ | VividQ develops computational holographic display technology for immersive visual experiences. | Hardware | Cambridge, United Kingdom | Series A | $7.5M | 2024-08-21 | Innovate UK, UTEC - The University of Tokyo Edge Capital Partners, APEX Ventures +2 | 11 to 50 | 2017 | |
| Red Arrow Therapeutics | Red Arrow Therapeutics is a biotech firm developing systemic cytokine delivery and targeted intratumoral activation. | Biotech | Minato, Japan | Seed | $4.5M | 2024-04-23 | MassChallenge, UTEC - The University of Tokyo Edge Capital Partners, Beyond Next Ventures +2 | 11 to 50 | 2021 | |
| Agara | Agara is a company providing autonomous voice agents powered by real-time voice AI to improve customer experience. | Artificial intelligence | Walnut, United States | Seed | $4.3M | 2021-01-28 | $7.3M | Kleiner Perkins, Blume Ventures, RTP Global +2 | 11 to 50 | 2017 |
Table 1. UTEC - The University of Tokyo Edge Capital Partners portfolio companies: the 9 newest rounds whose row carries a description, a city, a named fund and an amount. Source: FundingWatcher. Data as of 16 November 2026. Base: 24.
Largest rounds
Last 12 months| # | Company | What they do | Sector | Location | Last round | Amount | Date | Total raised | Investors | Employees | Founded |
|---|---|---|---|---|---|---|---|---|---|---|---|
| 1 | Mujin | Mujin provides automation solutions for industrial robots in factories and logistics. | Artificial intelligence | Tokyo, Japan | Series D | $224.9M | 2026-10-12 | $634.7M | SBI Investment, Pegasus Tech Ventures, UTEC - The University of Tokyo Edge Capital Partners | 251 to 500 | 2011 |
| 2 | BionicM | BionicM develops high-performance robotic prostheses that improve mobility for people with disabilities. | Hardware | Tokyo, Japan | Series B | $4.5M | 2026-11-02 | $15.5M | UTEC - The University of Tokyo Edge Capital Partners, UTokyo Innovation Platform, Shinsei Corporate Investment +1 | 11 to 50 | 2018 |
| 3 | Celaid Therapeutics | Celaid Therapeutics develops cell therapies for blood cancer, intractable blood diseases, and genetic disorders. | Biotech | Tokyo, Japan | Series B | $2.5M | 2026-10-05 | $17.1M | UTEC - The University of Tokyo Edge Capital Partners, Osaka University Venture Capital, Joyo Capital Partners | 1 to 10 | 2020 |
| 4 | Triorb | Triorb develops software and hardware solutions for robot mobility. | Hardware | Kitakyushu, Japan | Series B | $1.9M | 2026-08-07 | $28.7M | Mitsubishi UFJ Capital, UTEC - The University of Tokyo Edge Capital Partners, MIRAI SOUZOU | 11 to 50 | 2023 |
Table 2. UTEC - The University of Tokyo Edge Capital Partners portfolio companies: the 4 largest rounds of the last 12 months. Source: FundingWatcher. Data as of 16 November 2026.
Most active investors
By companies backed| # | Investor | Type | Location | Companies | Share | Funded, 12 months | Latest |
|---|---|---|---|---|---|---|---|
| 1 | UTokyo Innovation Platform | Startup accelerator | Tokyo, Japan | 4 | 17% | 1 | BionicM |
| 2 | Osaka University Venture Capital | Venture capital firm | Osaka, Japan | 2 | 8% | 1 | Celaid Therapeutics |
| 3 | Mitsubishi UFJ Capital | Corporate venture arm | Tokyo, Japan | 2 | 8% | 1 | Triorb |
| 4 | Blume Ventures | Private equity firm | Mumbai, India | 2 | 8% | ||
| 5 | Skyland Ventures | Startup incubator | Tokyo, Japan | 2 | 8% | ||
| 6 | Miyako Capital | Venture capital firm | Kyoto, Japan | 2 | 8% | ||
| 7 | Resona Bank | Venture capital firm | Osaka, Japan | 2 | 8% | ||
| 8 | SMBC Venture Capital | Corporate venture arm | Tokyo, Japan | 2 | 8% | ||
| 9 | Mizuho Capital | Venture capital firm | Tokyo, Japan | 2 | 8% | ||
| 10 | Pegasus Tech Ventures | Venture capital firm | San Jose, United States | 1 | 4% | 1 | Mujin |
| 11 | SBI Investment | Venture capital firm | Minato, Japan | 1 | 4% | 1 | Mujin |
| 12 | Shinsei Corporate Investment | Venture capital firm | Otemachi, Japan | 1 | 4% | 1 | BionicM |
| 13 | Chibagin Capital | Venture capital firm | Chiba, Japan | 1 | 4% | 1 | BionicM |
| 14 | Joyo Capital Partners | Venture capital firm | 1 | 4% | 1 | Celaid Therapeutics | |
| 15 | MIRAI SOUZOU | Venture capital firm | Tokyo, Japan | 1 | 4% | 1 | Triorb |
Table 3. UTEC - The University of Tokyo Edge Capital Partners portfolio companies: the funds recorded as investors in the most companies. Latest: companies they back that raised in the last 12 months. Source: FundingWatcher. Data as of 16 November 2026.
Sectors
| Sectors | Companies | Share | Total raised |
|---|---|---|---|
| Software | 19 | 79% | $721.0M |
| Artificial intelligence | 11 | 46% | $656.7M |
| Health care | 8 | 33% | $65.7M |
| Hardware | 7 | 29% | $690.1M |
| Biotech | 5 | 21% | $31.7M |
| Fintech | 2 | 8% | |
| Education | 1 | 4% | |
| Commerce | 1 | 4% | $55.0M |
Table 4. UTEC - The University of Tokyo Edge Capital Partners portfolio companies by sector. Source: FundingWatcher. Data as of 16 November 2026.
Funding stage
Table 5. UTEC - The University of Tokyo Edge Capital Partners portfolio companies by stage of the most recent round. Source: FundingWatcher. Data as of 16 November 2026.
Countries
| Countries | Companies | Share |
|---|---|---|
| Japan | 17 | 71% |
| Singapore | 3 | 12% |
| United States | 3 | 12% |
| United Kingdom | 1 | 4% |
Table 6. UTEC - The University of Tokyo Edge Capital Partners portfolio companies by headquarters country. Source: FundingWatcher. Data as of 16 November 2026.
Cities
Table 7. UTEC - The University of Tokyo Edge Capital Partners portfolio companies by headquarters city. Source: FundingWatcher. Data as of 16 November 2026.
Rounds by month
| Rounds by month | Companies | Share | Raised |
|---|---|---|---|
| November 2026 | 1 | 25% | $4.5M |
| October 2026 | 2 | 50% | $227.4M |
| August 2026 | 1 | 25% | $1.9M |
Table 8. UTEC - The University of Tokyo Edge Capital Partners portfolio companies: most recent round by month, last 12 months. Source: FundingWatcher. Data as of 16 November 2026.
Most recent round by year
| Most recent round by year | Companies | Share | Raised |
|---|---|---|---|
| 2026 | 4 | 17% | $233.8M |
| 2025 | 1 | 4% | $27.3M |
| 2024 | 4 | 17% | $38.6M |
| 2023 | 2 | 8% | $10.7M |
| 2022 | 2 | 8% | $10.2M |
| 2021 | 5 | 21% | $10.7M |
Table 9. UTEC - The University of Tokyo Edge Capital Partners portfolio companies by year of the most recent round. Source: FundingWatcher. Data as of 16 November 2026.
Founding year
| Founding year | Companies | Share |
|---|---|---|
| 2023 or later | 1 | 4% |
| 2020 to 2022 | 4 | 17% |
| 2015 to 2019 | 14 | 58% |
| 2010 to 2014 | 5 | 21% |
Table 10. UTEC - The University of Tokyo Edge Capital Partners portfolio companies by founding year. Source: FundingWatcher. Data as of 16 November 2026.
Team size
| Team size | Companies | Share |
|---|---|---|
| 1 to 10 | 2 | 8% |
| 11 to 50 | 15 | 62% |
| 51 to 100 | 4 | 17% |
| 101 to 250 | 1 | 4% |
| 251 to 500 | 2 | 8% |
Table 11. UTEC - The University of Tokyo Edge Capital Partners portfolio companies by headcount. Source: FundingWatcher. Data as of 16 November 2026.
Method
- A company is on this list when UTEC - The University of Tokyo Edge Capital Partners is recorded as one of its investors. On 16 November 2026 that is 24 companies.
- Stage, round, amount and date are those of the company's most recent funding round. Amounts are in US dollars as the source records them.
- The table prints the 9 newest rounds whose row is complete: a one-sentence description, a city, a named fund and an amount. The CSV carries all 24 rows: 3 have no round amount, 0 no city and 9 no website. The CSV carries domain, website, LinkedIn and the cached description sentence where present.
Sources, fields and exclusions of both files: Method.
Questions
- How many UTEC - The University of Tokyo Edge Capital Partners portfolio companies are on the list?
- 24, in the file dated 16 November 2026. 4 of them closed their most recent round in the last 12 months.
- What does the CSV contain?
- One row per company, 18 columns: name, domain, website, linkedin, description, founded, employees, city, region, country, sectors, funding_stage, last_round, last_round_date, last_round_usd, total_raised_usd, rounds, investors.
- How much does the list cost?
- $29 one-time for all 24 rows, no account. Every investor and every startup, two files, cost $99. With founder contacts, up to 2 founders or CEOs per company compiled to order and mailed within 24 hours, $199.
- What arrives after payment?
- At once: the CSV download link, on the page after payment and by mail.
- Can I see rows before buying?
- The 3 rows under the buy button are rows of the CSV with every column. The form below it mails 10 rows.
- How current is the data?
- The file is dated 16 November 2026. The download link serves the current file each time it is opened.
Not sure about the data?
Download a free 10-row sample first. No account, no payment.